Paragon Therapeutics, Inc.

Biotechnology company · Philadelphia, Pennsylvania, United States

Paragon Therapeutics, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Paragon Therapeutics at a glance

Typebiotechnology company
HeadquartersPhiladelphia, Pennsylvania, United States
Earliest incorporation on record2021
SEC CIK1861055

What does Paragon Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $10 million sold (2021).

Frequently asked questions about Paragon Therapeutics

Where is Paragon Therapeutics headquartered?

Paragon Therapeutics, Inc. is headquartered in Philadelphia, Pennsylvania, United States.

What does Paragon Therapeutics do?

Paragon Therapeutics, Inc. is a biotechnology company.

When was Paragon Therapeutics founded?

The earliest incorporation on record for Paragon Therapeutics, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences